War on DiseaseWar on Disease

Back to Treatments

Treatment

Emicizumab

1

Conditions

48

Trials

3,000

Participants

58%

Average Safety

Condition Evidence

Hemophilia

48 trials · 3,000 participants

95% effectiveness · 58% safety

Is it OK if we trade 1.22 of our 122 apocalypses for disease eradication in 36 years instead of 443?

Campaign

🗳️VotePlease take 30 seconds to end war and disease.
📜Read the TreatyThe full text of the treaty that redirects 1% of military spending to clinical trials. Read it, sign it, share it. Every signature from an official account is verified on the public ledger.
📊DashboardAssign humans Earth Optimization Tasks and track the assignments you created.
👥Sign for SomeoneSign the 1% Treaty for sick, dead, offline, or incapacitated humans who cannot sign it themselves. Direct signatures stay separate.
🏢Organizational SignatoriesOrganizations that signed the 1% Treaty.
✍️Sign as OrganizationSign the 1% Treaty as an organization.
💝DonateLess than a cent buys one year of healthy human life. About 50,000× cheaper than anti-malaria bed nets. Tax-deductible to a 501(c)(3).

Reference

🧠WhyWhat happens when one percent of the murder budget becomes medicine budget.
⚖️Court of HumanityJoin the decentralized court where 8 billion humans are the jury and sovereign immunity is a choice nobody chose. Verified members can seek justice against any government that kills, injures, or harms them or their family.

International Campaign to End War and Disease. Contact hello@warondisease.org.

Privacy·Terms·Legal

Emicizumab | DFDA